Archimed, the France based global healthcare private equity investor, has concluded its £203m (US$253m) take-private bid for drug development software developer UK-based Instem. Instem shareholders will receive 833 pence in…
Archimed, the France based global healthcare private equity investor, has concluded its £203m (US$253m) take-private bid for drug development software developer UK-based Instem. Instem shareholders will receive 833 pence in…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


